Nasser S Al-Shakliah Selected Research

GSK 1363089

8/2021

Response surface methodology for optimization of micellar-enhanced spectrofluorimetric method for assay of foretinib in bulk powder and human urine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nasser S Al-Shakliah Research Topics

Disease

4	Neoplasms (Cancer) 08/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 08/2021 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2020
1	Peripheral Arterial Disease 05/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2021
1	Thrombosis (Thrombus) 05/2021
1	Atrial Fibrillation 05/2021
1	Hemorrhage 05/2021
1	Pulmonary Embolism 05/2021
1	Melanoma (Melanoma, Malignant) 05/2021
1	Drug-Related Side Effects and Adverse Reactions 05/2021
1	Phototoxic Dermatitis (Phototoxicity) 09/2018
1	Floating-harbor syndrome 06/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2016

Drug/Important Bio-Agent (IBA)

5	Phosphotransferases (Kinase)IBA 08/2021 - 01/2020
4	tyrosine receptor (receptor, tyrosine)IBA 08/2021 - 01/2020
3	Tyrosine Kinase InhibitorsIBA 08/2021 - 08/2016
2	infigratinibIBA 08/2021 - 04/2020
2	tandutinibIBA 01/2021 - 01/2020
1	GSK 1363089IBA 08/2021
1	MicellesIBA 08/2021
1	TabletsIBA 08/2021
1	RivaroxabanIBA 05/2021
1	AnticoagulantsIBA 05/2021
1	encorafenibIBA 05/2021
1	binimetinibIBA 05/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 04/2020
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 01/2020
1	Surface-Active Agents (Surfactants)IBA 01/2020
1	Lapatinib (GW572016)FDA Link 01/2020
1	vandetanib (ZD6474)IBA 09/2018
1	Fluorescein (Funduscein)FDA LinkGeneric 06/2017
1	HydrazonesIBA 06/2017
1	Topoisomerase InhibitorsIBA 06/2017
1	AfatinibIBA 08/2016

Therapy/Procedure

2	Therapeutics 05/2021 - 01/2020